Human bone marrow-derived IgA is produced by IgA-committed B cells in vitro

Area of Science:

• Immunology
• Hematology

Background:

• Human bone marrow's role in immunoglobulin production is known, but antibody production kinetics and responsible cells remain unclear.
• Previous research indicated significant IgA secretion by bone marrow mononuclear cells in vitro.

Purpose of the Study:

• To investigate the kinetics of antibody production in human bone marrow.
• To identify the specific cells responsible for antibody production within the bone marrow.

Main Methods:

• Culturing human bone marrow mononuclear cells to assess IgA synthesis.
• Utilizing anti-alpha-chain and anti-mu-chain antisera to inhibit immunoglobulin production.
• Isolating and culturing IgA-bearing cells to evaluate their contribution to IgA secretion.

Main Results:

• Demonstrated de novo synthesis of IgA in bone marrow mononuclear cell cultures.
• Observed that peak IgA concentration preceded IgM in culture supernatants.
• Showed that anti-alpha-chain antiserum completely inhibited IgA production, while anti-mu-chain antiserum only partially inhibited it.
• Found that isolated IgA-bearing cells increased IgA concentration over 13-fold compared to unseparated cells.

Conclusions:

• Bone marrow produces IgA as a secondary or anamnestic response to an unknown stimulus.
• IgA-committed B cells within the bone marrow are responsible for in vitro IgA synthesis and secretion.